United Kingdom RUO Immunoassay Market Size, Share, Opportunities, And Trends By Product Type (Immunoassay Kits, Immunoassay Reagents, Microplate Reader, Microplates, Analyzers (Automated Analyzers, Non-Automated Analyzers), Microplate Washers, Others), By Sample Type (Plasma, Blood Serum, Urine, Saliva, Cell or Tissue Culture Medium, Others), By Application (Oncology, Blood Screening and Toxicology, Infectious Disease, Cardiology, Allergy Diagnostic, Rare and Emerging Condition Diagnostic, Others), By End-User (Research and Academic Laboratories, Pharmaceutical and Biotechnology Companies), And By State - Forecasts From 2025 To 2030

United Kingdom RUO Immunoassay Market Size:

The United Kingdom RUO immunoassay market is projected to grow at a CAGR of 10.57%  from 2025 to 2030.

United Kingdom RUO Immunoassay Market Trends:

The UK RUO immunoassay market is expanding with a growing focus on personalized medicine and testing. To capitalize on the opportunity, in April 2023, Oxford Nanopore and bioMérieux entered into a strategic partnership to develop innovative infectious disease diagnostics. Their partnership is to develop a new generation of nanopore-based molecular sensing that will help for rapid and accurate identification of microbial pathogens and associated antimicrobial resistance. Similarly, ImmunoServ on August 2023, launched the Immuno-T™ Laboratory Test Kit, which enables standardized and scalable T-cell testing to be performed in laboratories.

Moreover, Elecsys Anti-HEV IgM and Elecsys Anti-HEV IgG immunoassays were launched by the Roche Group, in November 2023, for the detection of hepatitis E virus (HEV) infections and treatment. Further, Avacta Group plc announced it had acquired Coris Bioconcept SRL in June 2023, for a cash of £7.4 million.

The UK's RUO immunoassay market is witnessing a significant upswing due to the focus on personalized treatments in cases of cancer. The mortality by cancer is going up, from 148,359 in 2021 to 152,833 in 2022. There is a growing focus of the government and private players for cancer research and a trend towards high funding allocation.

These developments are also backed by science and tech businesses through investments in critical life science manufacturing projects worth £92 million to increase health resilience, this is part of the wider government plan. Two prominent pharmaceutical companies have committed a total investment of £84 million into their manufacturing sites in the UK and are set to receive additional funding from the government.

Almac, in Northern Ireland, focuses on producing medications for diseases like cancer and heart disease. Meanwhile, Ortho Clinical Diagnostics, located in Pencoed, Wales, is expanding its testing capabilities to aid in the identification of various conditions and diseases.

 

United Kingdom RUO Immunoassay Market Scope:

Report Metric	Details
Growth Rate	CAGR of 10.57%
Study Period	2020 to 2030
Historical Data	2020 to 2023
Base Year	2024
Forecast Period	2025 – 2030
Forecast Unit (Value)	USD Billion
Segmentation	Product Type Sample Type Application End-User State
Geographical Segmentation	England, Scotland, Wales, Northern Ireland
List of Major Companies in the United Kingdom RUO Immunoassay Market	Abcam PLC DIAsource Immunoassay Danaher PerkinElmer, Inc Siemens Healthineers
Customization Scope	Free report customization with purchase

 

United Kingdom RUO Immunoassay Market Segmentation

By Product Type

• Immunoassay Kits
  • Enzyme-Linked Immunosorbent Assay (ELISA) Kits
    • Conventional
    • Manual
  • Radioimmunoassay (RIA Kits)
    • Conventional
    • Manual
  • Chemiluminescent Immunoassay (CLIA) Kits
• Immunoassay Reagents
• Microplate Reader
• Microplates
• Analyzers
  • Automated Analyzers
  • Non-Automated Analyzers
• Microplate Washers
• Others

By Sample Type

• Plasma
• Blood Serum
• Urine
• Saliva
• Cell or Tissue Culture Medium
• Others

By Application

• Oncology
• Blood Screening and Toxicology
• Infectious Disease
• Cardiology
• Allergy Diagnostic
• Rare and Emerging Condition Diagnostic
• Others

By End-User

• Research and Academic Laboratories
• Pharmaceutical and Biotechnology Companies

By State

• England
• Scotland
• Wales
• Northern Ireland

---

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

4.1. Product Pipeline

5. UNITED KINGDOM RUO IMMUNOASSAY MARKET BY PRODUCT TYPE

5.1. Introduction

5.2. Immunoassay Kits

5.2.1. Enzyme-Linked Immunosorbent Assay (ELISA) Kits

5.2.1.1. Conventional 

5.2.1.2. Manual

5.2.2. Radioimmunoassay (RIA Kits)

5.2.2.1. Conventional 

5.2.2.2. Manual

5.2.3. Chemiluminescent Immunoassay (CLIA) Kits

5.3. Immunoassay Reagents

5.4. Microplate Reader

5.5. Microplates

5.6. Analyzers

5.6.1. Automated Analyzers

5.6.2. Non-Automated Analyzers

5.7. Microplate Washers

5.8. Others

6. UNITED KINGDOM RUO IMMUNOASSAY MARKET BY SAMPLE TYPE

6.1. Introduction

6.2. Plasma 

6.3. Blood Serum

6.4. Urine

6.5. Saliva

6.6. Cell or Tissue Culture Medium

6.7. Others

7. UNITED KINGDOM RUO IMMUNOASSAY MARKET BY APPLICATION

7.1. Introduction

7.2. Oncology

7.3. Blood Screening and Toxicology

7.4. Infectious Disease

7.5. Cardiology

7.6. Allergy Diagnostic

7.7. Rare and Emerging Condition Diagnostic

7.8. Others

8. UNITED KINGDOM RUO IMMUNOASSAY MARKET BY END-USER

8.1. Introduction

8.2. Research and Academic Laboratories

8.3. Pharmaceutical and Biotechnology Companies

9. UNITED KINGDOM RUO IMMUNOASSAY MARKET BY COUNTRIES

9.1. Introduction

9.2. England

9.2.1. By Product Type

9.2.2. By Sample Type

9.2.3. By Application

9.2.4. By End-User

9.3. Scotland

9.3.1. By Product Type

9.3.2. By Sample Type

9.3.3. By Application

9.3.4. By End-User

9.4. Wales

9.4.1. By Product Type

9.4.2. By Sample Type

9.4.3. By Application

9.4.4. By End-User

9.5. Northern Ireland

9.5.1. By Product Type

9.5.2. By Sample Type

9.5.3. By Application

9.5.4. By End-User

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Market Share Analysis

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Competitive Dashboard

11. COMPANY PROFILES

11.1. Abcam PLC

11.2. DIAsource Immunoassay

11.3. Danaher

11.4. PerkinElmer, Inc

11.5. Siemens Healthineers

11.6. F. Hoffman La Roche Ltd.

11.7. Merck KGaA

12. APPENDIX

12.1. Currency 

12.2. Assumptions

12.3. Base and Forecast Years Timeline

12.4. Key benefits for the stakeholders

12.5. Research Methodology 

12.6. Abbreviations 

Abcam PLC

DIAsource Immunoassay

Danaher

PerkinElmer, Inc

Siemens Healthineers

Hoffman La Roche Ltd.

Merck KGaA